Performing a cost-effectiveness analysis: Surveillance of patients with ulcerative colitis

American Journal of Gastroenterology

Volumn 93, Issue 6, 1998, Pages 872-880

  Provenzale, Dawn ^a   Wong, John B ^b   Onken, Jane E ^b   Lipscomb, Joseph ^b  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; COLON CARCINOMA; COLON RESECTION; COLONOSCOPY; COST EFFECTIVENESS ANALYSIS; DYSPLASIA; HEALTH SURVEY; MEDICAL PRACTICE; PRIORITY JOURNAL; ULCERATIVE COLITIS;

BIOPSY; COLITIS, ULCERATIVE; COLONOSCOPY; COST-BENEFIT ANALYSIS; HUMANS; LIFE EXPECTANCY; MODELS, THEORETICAL; OUTCOME ASSESSMENT (HEALTH CARE); SENSITIVITY AND SPECIFICITY;

EID: 0032105425     PISSN: 00029270     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1572-0241.1998.00314.x     Document Type: Article

References (40)

1. 1. Provenzale D, Lipscomb J. Cost-effectiveness: Definitions and use in the gastroenterology literature. Am J Gastroenterol 1996;91:1488-93.
2. 2. Provenzale D, Lipscomb J. A reader's guide to economic analysis in the GI literature. Am J Gastroenterol 1996;91:2461-70.
3. 3. Drummond MF, Stoddart GL, Torrance GW. Methods for the economic evaluation of health care programs. Oxford: Oxford University Press, 1987.
4. 4. Ransohoff DF. Colon cancer in ulcerative colitis (Editorial). Ann Intern Med 1989;94:1089-92.
5. 5. Kewenter J, Ahlman H, Hulten L. Cancer risk in extensive ulcerative colitis. Ann Surg 1978;188:824-8.
6. 6. American Society for Gastrointestinal Endoscopy. Publication #1013. Manchester, 1986.
7. 7. Morson BC, Pang LSC. Rectal biopsy as an aid to cancer control in ulcerative colitis. Gut 1967;8:423-4.
8. 8. Provenzale D, Kowdley KV, Sanjeev A, et al. Prophylactic colectomy or surveillance for chronic ulcerative colitis? A decision analysis. Gastroenterology 1995;109:1188-96.
9. 9. Sonnenberg FA, Beck JR. Markov models in medical decision making: A practical guide. Med Decis Making 1993;13:322-38.
10. 10. National Center for Health Statistics. Vital statistics of the United States, 1987, Vol. II, mortality, Part A. Public Health Service, Washington, DC: U.S. Government Printing Office, 1990.
11. 11. Löfberg R. Cancer in ulcerative colitis. In: Munkholm P, Peña S, eds. IBD-The patient in focus. Kent, England: Wells Medical Ltd. Research & Clinical Forums, 1997;19:63-72.
12. 12. Finkler SA. The distinction between cost and charges. Ann Intern Med 1982;96:102-9.
13. 13. St. Anthony's DRG Working Guidebook. Reston, VA: St. Anthony Publishing, Inc., 1996.
14. 14. Bernstein CN, Shanahan F, Weinstein WM. Are we telling patients the truth about surveillance colonoscopy in ulcerative colitis? Lancet 1994;343:71-4.
15. 15. Connell WR, Lennard-Jones JE, Williams CB, et al. Factors affecting the outcome of endoscopic surveillance for cancer in ulcerative colitis. Gastroenterology 1994;107:934-44.
16. 16. Lipscomb J, Weinstein MC, Torrance GW. Time preference. In: Gold MK, Siegel JE, Russell LB, Weinstein MC, eds. Cost-effectiveness in health and medicine. New York: Oxford University Press, 1976:214-46.
17. 17. Detsky AS, Naglie IG. A clinician's guide to cost-effectiveness analysis. Ann Intern Med 1990;113:147-54.
18. 18. Eddy DM. Screening for cervical cancer. Ann Intern Med 1990; 113: 214-26.
19. 19. Berwick DM, Cretin S, Keeler E. Cholesterol, children, and heart disease: An analysis of alternatives. New York: Oxford University Press, 1980:272-3.
20. 20. Pennock JL, Pyer PE, Reitz BA, et al. Cardiac transplantation in perspective for the future: Survival, complications, rehabilitation, and cost. J Thorac Cardiovasc Surg 1982;83:168-77.
21. 21. Gold MR, Siegel JE, Russell LB, et al. Cost-effectiveness in health and medicine. New York: Oxford University Press, 1996.
22. 22. Collins RH, Feldman M, Fordtran JS. Sounding board. Colon cancer, dysplasia, and surveillance in patients with ulcerative colitis-A critical review. New Engl J Med 1987;316:1654-8.
23. 23. Lashner BA, Hanauer SB, Silverstein MD. Optimal timing of colonoscopy to screen for cancer in ulcerative colitis. Ann Intern Med 1988; 108:274-8.
24. 24. Lashner BA, Kane KA, Hanauer SB. Colon cancer surveillance in chronic ulcerative colitis: Historical cohort study. Am J Gastroenterol 1990;85:1083-7.
25. 25. Rutgard JN, Ahsgren LR, Janunger KG. Ulcerative colitis-Colorectal cancer risk in an unselected population. Ann Surg 1988;208:721-4.
26. 26. Lennard-Jones JE, Morson BC, Ritchie JK, et al. Cancer surveillance in ulcerative colitis-Experience over 15 years. Lancet 1983;2: 149-52.
27. 27. Provenzale D, Shearin M, Phillip-Bute B, et al. Health related quality of life of ileoanal pull-through: Evaluation and assessment of new health status measures. Gastroenterology 1997;113:7-14.
28. 28. Lynch DAF, Lobo AJ, Solbala GM, et al. Failure of colonoscopic surveillance in ulcerative colitis. Gut 1993;34:1075-80.
29. 29. Jones HW, Grogono J, Hoare AM. Surveillance in ulcerative colitis, burdens, and benefits. Gut 1988;29:325-31.
30. 30. Leidenius M, Kellokumpu I, Husa A, et al. Dysplasia and carcinomas in long-standing ulcerative colitis: An endoscopic and histological surveillance program. Gut 1991;32:1521-5.
31. 31. Lashner BA, Hanauer SB, Silverstein MD. Optimal timing for colonoscopy to screen for cancer in ulcerative colitis. Ann Intern Med 1988; 274:78.
32. 32. Rutegard J, Ahsgren L, Stenling R, et al. Cancer surveillance in an unselected population. Scand J Gastroenterol 1988;23:139-45.
33. 33. van der Mass PJ, de Konig JG, van Ineveld BM, et al. The cost-effectiveness of breast cancer screening. Int J Cancer 1989;43:1055-60.
34. 34. Miller JS, Ferguson CM, Amerson JR, et al. Ileal pouch-anal anastomosis. The Emory University experience. Am Surg 1991;57:89-95.
35. 35. Eddy DM. Screening for colorectal cancer. Ann Intern Med 1990;113: 373-84.
36. 36. Gyde S, Prior P, Thompson H, et al. Survival of patients with cancer complicating ulcerative colitis. Gut 1984;25:228-31.
37. 37. Lavery IC, Chiulli RA, Jagelman DG, et al. Survival with carcinoma arising in mucosal ulcerative colitis. Ann Surg 1982;195:508-12.
38. 38. Brostrom O, Löfberg R, Nordenvall B, et al. The risk of colorectal cancer in ulcerative colitis: An epidemiologic study. Scand J Gastroenterol 221:1193-9.
39. 39. Rosenstock E, Farmer R, Petras R, et al. Surveillance for colonic carcinoma in ulcerative colitis. Gastroenterology 1985;89:1342-6.
40. 40. Langholz E, Munkholm P, Davidsen M, et al. Colorectal cancer risk and mortality in patients with ulcerative colitis. Gastroenterology 1992;103:1444-51.